토토랜드s
-
- Investor Relations
-
토토랜드 Shokubai to Exhibit at European Coatings Show (ECS) 2025
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Management and Business
토토랜드 Shokubai Announces Shares Acquisition of Lilac pharma (to Make It a Subsidiary)
-
- Management and Business
- Investor Relations
-
- Management and Business
- Sustainability
-
- Management and Business
-
- Management and Business
- Sustainability
-
- Management and Business
- Sustainability
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Sustainability
- Investor Relations
토토랜드 Shokubai Published “TechnoAmenity Report 2024,” and “Financial Report 2024.”
-
- Sustainability
- Management and Business
-
- Sustainability
- Research and 토토랜드
-
- Sustainability
- Research and 토토랜드
-
- Sustainability
- Management and Business
-
- Sustainability
- Investor Relations
토토랜드 Shokubai published “TechnoAmenity Report 2023”, “RC Report 2023”, and “Financial Report 2023.”
-
- Research and 토토랜드
3D Cell Culture Vessel “MicoCell™” First Application in Regenerative Medicine
-
- Research and 토토랜드
-
- Research and 토토랜드
-
- Research and 토토랜드
-
- Research and 토토랜드
- Announce
-
- Research and 토토랜드
- Announce
-
- Announce
- Research and 토토랜드
-
- Announce
- Research and 토토랜드
-
- Announce
- Research and 토토랜드
-
- Announce
- Research and 토토랜드
-
- Announce
-
- Announce
- Research and 토토랜드